1. 1. Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE. Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 1997;15;765(2):283-90.
2. 2. Bao F, Brown A, Dekaban GA, Omana V, Weaver LC. CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp. Neurol. 2011;231(2):272-83.
3. 3. Wrathall JR, Teng YD, Choiniere D. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl- D-aspartate receptors. Exp. Neurol. 1996;137(1):119-26.
4. 4. Benevento BT, Sipski ML: Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury. Phys. Ther. 2002;82:601–12.
5. 5. S. Kobayashi, M.L. Bannister, J.P. Gangopadhyay, T. Hamada, J. Parness, N. Ikemoto, Dantrolene stabilizes domain interactions within the ryanodine receptor, J. Biol. Chem. 2005;280; 6580–7.